Clinical trial
A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as…
NCT00212797 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00212797 |
|---|---|
| Title | A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845) |
| Official title | Prospective, Double-Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunctive Therapy in Subjects With Psychotic Major Depression (Major Depressive Episode, Severe, With Psychotic Features). |
| Acronym | Hermes |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression, Depressive Disorders, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Org 34517, Placebo |
| Enrollment | 273 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 26, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: